Cargando…

Primary Sjögren's syndrome as independent risk factor for subclinical atherosclerosis

OBJECTIVE: To assess the prevalence of subclinical atherosclerosis in patients with primary Sjögren's syndrome (pSS) and its possible association with clinical and analytical parameters of the disease. METHODS: In this cross-sectional study, 38 consecutive patients with pSS were compared with 3...

Descripción completa

Detalles Bibliográficos
Autores principales: Novella-Navarro, Marta, Cabrera-Alarcón, José Luis, Rosales-Alexander, José Luis, González-Martín, Jorge Juan, Carrión, Ofelia, de la Peña, Paloma García
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medical Research and Education Association 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089143/
https://www.ncbi.nlm.nih.gov/pubmed/35110133
http://dx.doi.org/10.5152/eurjrheum.2021.20093
_version_ 1785022707405946880
author Novella-Navarro, Marta
Cabrera-Alarcón, José Luis
Rosales-Alexander, José Luis
González-Martín, Jorge Juan
Carrión, Ofelia
de la Peña, Paloma García
author_facet Novella-Navarro, Marta
Cabrera-Alarcón, José Luis
Rosales-Alexander, José Luis
González-Martín, Jorge Juan
Carrión, Ofelia
de la Peña, Paloma García
author_sort Novella-Navarro, Marta
collection PubMed
description OBJECTIVE: To assess the prevalence of subclinical atherosclerosis in patients with primary Sjögren's syndrome (pSS) and its possible association with clinical and analytical parameters of the disease. METHODS: In this cross-sectional study, 38 consecutive patients with pSS were compared with 38 age and sex healthy controls. Demographic variables and classic cardiovascular risk factors (CVRFs): Hypertension, dyslipidemia, diabetes mellitus, obesity, and smoking habit were assessed in both groups, and also disease-related features were collected in pSS group. The presence of subclinical atherosclerosis was assessed by carotid ultrasound, with carotid intima-media thickness (CIMT) measurement and determination of the presence of atheromatous plaques. RESULTS: Subclinical atherosclerosis presence was remarkably greater in patients with pSS than in healthy controls (OR = 4.17, 95%CI [1.27-16.54]), as well as CIMT values (0.79 ± 0.43 mm vs. 0.66 ± 0.27 mm; P = .02). No differences for classic CVRFs were found between both groups. An association of subclinical atherosclerosis with erythrocyte sedimentation rate (ESR) and rheumatoid factor (RF) was observed in patients with pSS. CONCLUSION: This cohort showed a greater prevalence of subclinical atherosclerosis in patients with pSS, indicating this disease as an independent risk factor for presence of early vascular damage.
format Online
Article
Text
id pubmed-10089143
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Medical Research and Education Association
record_format MEDLINE/PubMed
spelling pubmed-100891432023-04-12 Primary Sjögren's syndrome as independent risk factor for subclinical atherosclerosis Novella-Navarro, Marta Cabrera-Alarcón, José Luis Rosales-Alexander, José Luis González-Martín, Jorge Juan Carrión, Ofelia de la Peña, Paloma García Eur J Rheumatol Original Article OBJECTIVE: To assess the prevalence of subclinical atherosclerosis in patients with primary Sjögren's syndrome (pSS) and its possible association with clinical and analytical parameters of the disease. METHODS: In this cross-sectional study, 38 consecutive patients with pSS were compared with 38 age and sex healthy controls. Demographic variables and classic cardiovascular risk factors (CVRFs): Hypertension, dyslipidemia, diabetes mellitus, obesity, and smoking habit were assessed in both groups, and also disease-related features were collected in pSS group. The presence of subclinical atherosclerosis was assessed by carotid ultrasound, with carotid intima-media thickness (CIMT) measurement and determination of the presence of atheromatous plaques. RESULTS: Subclinical atherosclerosis presence was remarkably greater in patients with pSS than in healthy controls (OR = 4.17, 95%CI [1.27-16.54]), as well as CIMT values (0.79 ± 0.43 mm vs. 0.66 ± 0.27 mm; P = .02). No differences for classic CVRFs were found between both groups. An association of subclinical atherosclerosis with erythrocyte sedimentation rate (ESR) and rheumatoid factor (RF) was observed in patients with pSS. CONCLUSION: This cohort showed a greater prevalence of subclinical atherosclerosis in patients with pSS, indicating this disease as an independent risk factor for presence of early vascular damage. Medical Research and Education Association 2022-02-08 /pmc/articles/PMC10089143/ /pubmed/35110133 http://dx.doi.org/10.5152/eurjrheum.2021.20093 Text en © Copyright by 2022 Medical Research and Education Association https://creativecommons.org/licenses/by-nc/4.0/ Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Original Article
Novella-Navarro, Marta
Cabrera-Alarcón, José Luis
Rosales-Alexander, José Luis
González-Martín, Jorge Juan
Carrión, Ofelia
de la Peña, Paloma García
Primary Sjögren's syndrome as independent risk factor for subclinical atherosclerosis
title Primary Sjögren's syndrome as independent risk factor for subclinical atherosclerosis
title_full Primary Sjögren's syndrome as independent risk factor for subclinical atherosclerosis
title_fullStr Primary Sjögren's syndrome as independent risk factor for subclinical atherosclerosis
title_full_unstemmed Primary Sjögren's syndrome as independent risk factor for subclinical atherosclerosis
title_short Primary Sjögren's syndrome as independent risk factor for subclinical atherosclerosis
title_sort primary sjögren's syndrome as independent risk factor for subclinical atherosclerosis
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10089143/
https://www.ncbi.nlm.nih.gov/pubmed/35110133
http://dx.doi.org/10.5152/eurjrheum.2021.20093
work_keys_str_mv AT novellanavarromarta primarysjogrenssyndromeasindependentriskfactorforsubclinicalatherosclerosis
AT cabreraalarconjoseluis primarysjogrenssyndromeasindependentriskfactorforsubclinicalatherosclerosis
AT rosalesalexanderjoseluis primarysjogrenssyndromeasindependentriskfactorforsubclinicalatherosclerosis
AT gonzalezmartinjorgejuan primarysjogrenssyndromeasindependentriskfactorforsubclinicalatherosclerosis
AT carrionofelia primarysjogrenssyndromeasindependentriskfactorforsubclinicalatherosclerosis
AT delapenapalomagarcia primarysjogrenssyndromeasindependentriskfactorforsubclinicalatherosclerosis